EE742 Unlocking the Value of RSV Adult Vaccination With Adjuvanted RSVpreF3 Vaccine in Germany: A Return on Investment Analysis Using an Integrated Actuarial-Macroeconomic Model
Abstract
Authors
Eleftherios Zarkadoulas Alen Marijam Maria Waize Alexandra Kostakis Attila Mihalyi Nikos Kotsopoulos